secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001104659-23-080805
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 2.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA acquires Spindle Biotech for $625K cash + stock; launches LineaIVT mRNA platform
--------------------------------------------------------------------------------

- Total consideration: $625K cash, 750K restricted shares, up to 1M earn-out shares, and 10-year revenue share.
- Spindle's RNA polymerase combined with Applied DNA's linearDNA templates reduces dsRNA contamination in mRNA production.
- Aaron Chung, Spindle co-founder and CEO, joins Applied DNA as Director of Nucleic Acid Platforms.
- LineaIVT platform launched with early access program; targets >20% of mRNA manufacturing COGS.
- Transaction accounted for as asset acquisition; financials consolidated from July 12, 2023 closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465923080805/0001104659-23-080805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465923080805/tm2321212d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-080805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer